Literature DB >> 8631701

Inner core biosynthesis of lipooligosaccharide (LOS) in Neisseria meningitidis serogroup B: identification and role in LOS assembly of the alpha1,2 N-acetylglucosamine transferase (RfaK).

C M Kahler1, R W Carlson, M M Rahman, L E Martin, D S Stephens.   

Abstract

A lipooligosaccharide (LOS) mutant of Neisseria meningitidis serogroup B strain NMB (immunotype L3,7,9) was identified in a Tn916 (tetM) mutant bank by loss of reactivity with monoclonal antibody 3F11, which recognizes the terminal Galbeta1-->4GlcNAc epitope in the lacto-N-neotetraose moiety of the wild-type LOS structure. The mutant, designated 559, was found to express a truncated LOS of 3.0 kDa. Southern and PCR analyses demonstrated that there was a single intact Tn916 insertion (class I) in the mutant 559 chromosome. Linkage of the LOS phenotype and the Tn916 insertion was confirmed by transformation of the wild-type parent. Nucleotide sequence analysis of the region surrounding the transposition site revealed a 1,065-bp open reading frame (ORF). A homology search of the GenBank/EMBL database revealed that the amino acid sequence of this ORF had 46.8% similarity and 21.2% identity with the alpha1,2 N-acetylglucosamine transferase (RfaK) from Salmonella typhimurium. Glycosyl composition and linkage analysis of the LOS produced by mutant 559 revealed that the lacto-N-neotetraose group which is attached to heptose I (HepI) and the N-acetylglucosamine and glucose residues that are attached to HepII in the inner core of the parental LOS were absent. These analyses also showed that the HepII residue in both the parent and the mutant LOS molecules was phosphorylated, presumably by a phosphoethanolamine substituent. The insertion of nonpolar and polar antibiotic resistance cartridges into the parental rfaK gene resulted in the expression of LOS with the same mobility as that produced by mutant 559. This result indicated that the inability to add the lacto-N-neotetraose group to the 559 LOS is not due to a polar effect on a gene(s) downstream of rfaK. Our data indicate that we have identified the meningococcal alpha1,2 N-acetylglucosamine transferase responsible for the addition of N-acetylglucosamine to HepII. We propose that the lack of alpha-chain extension from HepI in the LOS of mutant 559 may be due to structural constraints imposed by the incomplete biosynthesis of the LOS inner core.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631701      PMCID: PMC177798          DOI: 10.1128/jb.178.5.1265-1273.1996

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  56 in total

1.  Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: the synergistic effect of LPS and pili.

Authors:  K L Dunn; M Virji; E R Moxon
Journal:  Microb Pathog       Date:  1995-02       Impact factor: 3.738

2.  Lipooligosaccharide biosynthesis in Neisseria gonorrhoeae: cloning, identification and characterization of the alpha 1,5 heptosyltransferase I gene (rfaC)

Authors:  D Zhou; N G Lee; M A Apicella
Journal:  Mol Microbiol       Date:  1994-11       Impact factor: 3.501

3.  Lipooligosaccharide biosynthesis in pathogenic Neisseria. Cloning, identification, and characterization of the phosphoglucomutase gene.

Authors:  D Zhou; D S Stephens; B W Gibson; J J Engstrom; C F McAllister; F K Lee; M A Apicella
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

4.  Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis.

Authors:  M P Jennings; P van der Ley; K E Wilks; D J Maskell; J T Poolman; E R Moxon
Journal:  Mol Microbiol       Date:  1993-10       Impact factor: 3.501

5.  Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model.

Authors:  F G Mackinnon; R Borrow; A R Gorringe; A J Fox; D M Jones; A Robinson
Journal:  Microb Pathog       Date:  1993-11       Impact factor: 3.738

6.  A mutation in the Neisseria gonorrhoeae rfaD homolog results in altered lipooligosaccharide expression.

Authors:  E S Drazek; D C Stein; C D Deal
Journal:  J Bacteriol       Date:  1995-05       Impact factor: 3.490

7.  Tn916-generated, lipooligosaccharide mutants of Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  D S Stephens; C F McAllister; D Zhou; F K Lee; M A Apicella
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

8.  A lipooligosaccharide-binding site on HepG2 cells similar to the gonococcal opacity-associated surface protein Opa.

Authors:  N Porat; M A Apicella; M S Blake
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

9.  Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB.

Authors:  F K Lee; D S Stephens; B W Gibson; J J Engstrom; D Zhou; M A Apicella
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

10.  Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A.

Authors:  K Nummila; I Kilpeläinen; U Zähringer; M Vaara; I M Helander
Journal:  Mol Microbiol       Date:  1995-04       Impact factor: 3.501

View more
  25 in total

1.  Polymorphisms in pilin glycosylation Locus of Neisseria meningitidis expressing class II pili.

Authors:  C M Kahler; L E Martin; Y L Tzeng; Y K Miller; K Sharkey; D S Stephens; J K Davies
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 2.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Genetic basis for biosynthesis of the (alpha 1-->4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X.

Authors:  Yih-Ling Tzeng; Corie Noble; David S Stephens
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

4.  Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis.

Authors:  Margaret Anne J Gidney; Joyce S Plested; Suzanne Lacelle; Philip A Coull; J Claire Wright; Katherine Makepeace; Jean-Robert Brisson; Andrew D Cox; E Richard Moxon; James C Richards
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci.

Authors:  Yanwen Li; Yao-hui Sun; Cathy Ison; Myron M Levine; Christoph M Tang
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Yersinia pestis is viable with endotoxin composed of only lipid A.

Authors:  Li Tan; Creg Darby
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

7.  The structure of the L9 immunotype lipooligosaccharide from Neisseria meningitidis NMA Z2491.

Authors:  Biswa Choudhury; Charlene M Kahler; Anup Datta; David S Stephens; Russell W Carlson
Journal:  Carbohydr Res       Date:  2008-09-02       Impact factor: 2.104

8.  Identification of tandem genes involved in lipooligosaccharide expression by Haemophilus ducreyi.

Authors:  M K Stevens; J Klesney-Tait; S Lumbley; K A Walters; A M Joffe; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

9.  The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.

Authors:  C M Kahler; L E Martin; G C Shih; M M Rahman; R W Carlson; D S Stephens
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage.

Authors:  Constance M John; Nancy J Phillips; Richard Din; Mingfeng Liu; Einar Rosenqvist; E Arne Høiby; Daniel C Stein; Gary A Jarvis
Journal:  J Biol Chem       Date:  2015-12-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.